SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-005518
Filing Date
2015-01-30
Accepted
2015-01-30 07:57:38
Documents
7
Period of Report
2015-01-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-3416_18k.htm 8-K 24380
2 EX-99.1 a15-3416_1ex99d1.htm EX-99.1 666807
3 GRAPHIC g34161mo01i001.jpg GRAPHIC 2009
4 GRAPHIC g34161mo05i001.jpg GRAPHIC 1878
5 GRAPHIC g34161mo07i001.jpg GRAPHIC 1726
6 GRAPHIC g34161mo09i001.jpg GRAPHIC 1878
7 GRAPHIC g34161mo03i001.jpg GRAPHIC 2009
  Complete submission text file 0001104659-15-005518.txt   706122
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 15560797
SIC: 2834 Pharmaceutical Preparations